Tivorsan Pharmaceuticals

About:

Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.

Top Investors: Parent Project Muscular Dystrophy, MDA

Description:

Tivorsan Pharmaceuticals is a protein therapeutics company pioneering a unique approach to treating serious neuromuscular disorders, including DMD and Becker Muscular Dystrophy (BMD).

Total Funding Amount:

$13.3M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Providence, Rhode Island, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)tivorsan.com

Founders:

Joel B. Braunstein

Number of Employees:

1-10

Last Funding Date:

2017-03-17

IPO Status:

Private

Industries: